TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03542812

L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The study stopped enrollment prior to the initially projected 18 subjects per phase due to lack of funding to continue to recertify the drug and because an adequate number of subjects were enrolled for each phase to analyze pharmacokinetics.”

The sponsor’s own words in the registry.

Life of this trial

20182019202020212022202320242025Registered2018-05-02Started2019-07-30Stopped2022-08-31Results posted2024-05-02

Vital statistics

Status
Terminated
Phase
Early Phase 1
Sponsor
University of Utah
Sponsor type
University, hospital or other
Conditions
Infant,Premature; Bronchopulmonary Dysplasia; Pulmonary Hypertension
Interventions
L-Citrulline
Participants
16
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.